List of Figures

Figure 2.1.  Projected Population, by Race

Figure 2.2.  Projected Population Age Distribution, in Years 2014, 2032 & 2050

Figure 3.1.1.   Projected Prevalent Population of Vision Problems, by Year

Figure 3.1.2.   2014 Prevalence of Vision Problems, by Age

Figure 3.2.1.   Age Distribution of Current Glaucoma Population.

Figure 3.2.2.   Glaucoma Population by Age Group, 2014, 2032 & 2050

Figure 3.2.3.   Projected Glaucoma Population by Sex and Year

Figure 3.2.4.   Projected Glaucoma Population by Race and Year

Figure 3.2.5.   Projected Glaucoma Population by Race, 2014, 2032 & 2050

Figure 3.3.1.   Age Distribution of Current Cataract Population

Figure 3.3.2.   Projected Cataract Population by Age Group and Year

Figure 3.3.3.   Projected Cataract Population by Sex and Year

Figure 3.3.4.   Projected Cataract Population by Race and Year

Figure 3.3.5.   Projected Cataract Population by Race, 2014, 2032 & 2050

Figure 3.4.1.   Age Distribution of Current AMD Population

Figure 3.4.2.   Projected AMD Population by Age Group, 2014, 2032 & 2050

Figure 3.4.3.   Projected AMD Population by Sex and Year

Figure 3.4.4.   Projected AMD Population by Race and Year

Figure 3.5.1.   Age Distribution of Current Diabetic Retinopathy Population

Figure 3.5.2.   Projected Diabetic Retinopathy Population by Age Group, 2014, 2032 & 2050

Figure 3.5.3.   Projected Diabetic Retinopathy Population by Sex and Year

Figure 3.5.4.   Projected Diabetic Retinopathy Population by Race and Year

Figure 3.5.5.   Projected Diabetic Retinopathy Population by Race, 2014, 2032 & 2050

Figure 3.6.1.   Age Distribution of Current Visually Impaired Population

Figure 3.6.2.   Age Distribution of Current Blind Population

Figure 3.6.3.   Projected Visually Impaired Population by Age Group, 2014, 2032 & 2050

Figure 3.6.4.   Projected Blind Population by Age Group, 2014, 2032 & 2050

Figure 3.6.5.   Projected Visually Impaired Population by Sex and Year

Figure 3.6.6.   Projected Blind Population by Sex and Year

Figure 3.6.7.   Projected Visually Impaired Population by Race and Year

Figure 3.6.8.   Projected Blind Population by Race and Year

Figure 4.1.  Projected Total Costs, 2014 Real Costs and Nominal Expenditures, $billions

Figure 4.2.1.   Distribution of Costs by Age in 2014, 2032 & 2050, 2014 $billions

Figure 4.2.2.   Distribution of Expenditures by Age in 2014, 2032 & 2050, Nominal $billions

Figure 4.2.3.   Total Costs by Age Group in 2014, 2032 & 2050, 2014 $billions.

Figure 4.2.4.   Share of Total Costs by Age Group in 2014, 2032 & 2050, 2014 $billions

Figure 4.3.1.   Projected Total Costs by Payer

Figure 4.4.1.   Projected Total Costs by Category, 2014, 2032 & 2050

Figure 4.4.2.   Projected Total Costs by Category, $billions

Figure 4.5.1.   Projected Medical Treatment Costs by Disorder Type, 2014 $billions

Figure 4.5.2.   Projected Medical Treatment Costs by Diagnosed Disorder, 2014 $billions

Figure 5.1. 95% Confidence Intervals of Prevalence Projections

Figure 5.2.  95% Confidence Intervals of Cost Projections

Figure 6.1.  Predicted Annualized Prevalence versus Age-bin Prevalence

Figure 6.2.  Projected Total Costs, Real versus Nominal Costs, $billions